Novasep latest firm to invest in ADC capacity
Novasep has joined the growing number of manufacturers betting on the antibody drug conjugate (ADC) market with a €3m investment at its plant in Le Mans, France.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs